Monogram Technologies Inc
MGRM
Company Profile
Business description
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
Contact
3913 Todd Lane
Suite 307
AustinTX78744
USAT: +1 512 399-2656
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
28
Stocks News & Analysis
stocks
Vote in favour of merger for undervalued ASX share
We recommend shareholders vote in favor of its proposed merger.
stocks
Are investors missing the boat on this future ASX leader?
The market is underestimating the clear path to profitability.
stocks
ASX shares plunge but remain undervalued
Shares drop 17% after guidance is revised but we still see value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,569.10 | 112.30 | 1.33% |
| CAC 40 | 7,634.74 | 160.15 | 2.14% |
| DAX 40 | 20,655.39 | 80.71 | 0.39% |
| Dow JONES (US) | 43,241.03 | 19.48 | 0.05% |
| FTSE 100 | 8,391.90 | 90.77 | 1.09% |
| HKSE | 19,522.89 | 236.82 | 1.23% |
| NASDAQ | 19,450.63 | 60.60 | -0.31% |
| Nikkei 225 | 38,572.60 | 128.02 | 0.33% |
| NZX 50 Index | 13,000.67 | 57.10 | 0.44% |
| S&P 500 | 5,952.97 | 3.06 | 0.05% |
| S&P/ASX 200 | 8,327.00 | 113.70 | 1.38% |
| SSE Composite Index | 3,236.03 | 8.92 | 0.28% |